Capital Guardian Trust’s Zimmer Biomet ZBH Stock Holding History

Capital Guardian Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-82	Closed	-$9K	–	287
2017 Q3	$9K	Buy	+82	New	+$9.47K	﹤0.01%	246
2017 Q2	–	Sell	-745	Closed	-$88K	–	565
2017 Q1	$88K	Sell	745 -521	-41%	-$59K	﹤0.01%	398
2016 Q4	$127K	Buy	1,266 +434	+52%	+$46.5K	﹤0.01%	382
2016 Q3	$105K	Buy	832 +87	+12%	+$10.7K	﹤0.01%	380
2016 Q2	$87K	Hold	745	–	–	﹤0.01%	393
2016 Q1	$77K	Hold	745	–	–	﹤0.01%	401
2015 Q4	$74K	Hold	745	–	–	﹤0.01%	421
2015 Q3	$68K	Hold	745	–	–	﹤0.01%	411
2015 Q2	$79K	Hold	745	–	–	﹤0.01%	408
2015 Q1	$85K	Buy	+745	New	+$85K	﹤0.01%	405
2014 Q4	–	Sell	-31	Closed	-$3K	–	631
2014 Q3	$3K	Buy	+31	New	+$3.05K	﹤0.01%	570

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Guardian Trust's ZBH Position: Q4 2017 in Review

Capital Guardian Trust sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 82 shares — an estimated $9K sold.

Capital Guardian Trust first reported a position in ZBH in Q3 2014 and held it in 11 quarters. The position peaked at $127K in Q4 2016. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

Capital Guardian Trust reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
Capital Guardian Trust sold 82 Zimmer Biomet shares in Q4 2017, an estimated $9K.
Capital Guardian Trust first reported a position in Zimmer Biomet in Q3 2014 and held it in 11 quarters.
Capital Guardian Trust's Zimmer Biomet position peaked at $127K in Q4 2016.
870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Capital Guardian Trust's 13F filing for Q4 2017, filed 14 Feb 2018.